Because mutated p53 epitopes must have HLA anchoring motifs for the induction of CD8+ T cell responses, more patients must be evaluated to demonstrate the presence or absence of mutated p53-specific CD8+ T cells and their spontaneous activation in cancer patients. The gene discussed is TP53; the disease is cancer.